Testing Latest Version of NidekRS3000Adv

Doheny Image Reading Center100 enrolled

Overview

The investigators would like to know if different imaging devices can improve the quality of images and visualization of imaged tissues. Also, the investigators would like to find out whether these changes are useful in the diagnosis and treatment of eye diseases. Using images of previous participants will allow us to demonstrate the advancement of different technologies, as well be used to allow comparisons between current technologies.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Glaucoma

Interventions

RS3000AdvDEVICE

Nidek RS3000Adv device to be used to take images which will allow measurement of vascularization in participants

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Healthy participants * 18 years old or older Exclusion Criteria: * Those suffering from head, neck or other injury which makes them unable to position themselves in head restraint for imaging * subjects who are unable to maintain retinal fixation on a specified target * subjects unable to achieve sufficient pupil dilation and alignment stability for imaging to take place * subjects with media opacity which preclude high quality imaging will be excluded. * vulnerable subjects * subjects under 18 * pregnant subjects * economically and educationally disadvantaged subjects * decision impaired subjects * homeless subjects

Locations (1)

Doheny Eye Centers UCLA

Pasadena, California, United States

Outcomes

Primary Outcomes

Ocular vascularization

Nidek RS3000Adv device to be used to take images which will allow measurement of vascularization in participants

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.